Afleveringen
-
Just a couple of weeks ago, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents gathered in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum.
Dr. Mikael Simons is a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases in Munich, Germany, and he's this year's recipient of the Barancik Prize for Innovation in MS Research.
At the ACTRIMS Forum, we talked with Dr. Simons about his research in myelin repair.
We have a lot to talk about! Are you ready for RealTalk MS??!
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/actrims06
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode
Guest: Dr. Mikael SimonsPrivacy Policy
-
Just a couple of weeks ago, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents gathered in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum.
Dr. Daniel Reich is a neurologist and neuroradiologist. He is the Director of the Translational Neuroradiology Section at the NIH National Institute of Neurological Disorders and Stroke. In his clinical practice, Dr. Reich cares for people living with MS and other neurological diseases, and he leads several clinical trials focused on multiple sclerosis.
At the ACTRIMS Forum, we talked with Dr. Reich about myelin repair, how improvements in imaging have impacted diagnosing and treating MS, and what he sees in MS research today that has him excited.
We have a lot to talk about! Are you ready for RealTalk MS??!
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/actrims05
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode
Guest: Dr. Daniel ReichPrivacy Policy
-
Zijn er afleveringen die ontbreken?
-
Just a couple of weeks ago, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents gathered in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum.
Dr. Christina Azevedo is an Associate Professor of Neurology at the University of Southern California.
At the ACTRIMS Forum, we talked with Dr. Azevedo about updates to the McDonald criteria, which are the criteria used to diagnose MS, and the benefits of getting an early MS diagnosis.
We have a lot to talk about! Are you ready for RealTalk MS??!
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/actrims04
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode
Guest: Dr. Christina AzevedoPrivacy Policy
-
Just a couple of weeks ago, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents gathered in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum.
Dr. Peter Calabresi is the Director of the Division of Neuroimmunology and the Director of the Multiple Sclerosis Center at Johns Hopkins Medicine, focusing on the diagnosis and management of MS. He is the principal investigator on several clinical trials and oversees research projects focused on creating new anti-inflammatory and neuroprotective therapies for MS.
At the ACTRIMS Forum, we talked with Dr. Calabresi about updates to the criteria used to diagnose MS, the importance and benefit of identifying biomarkers for MS, and what he sees in MS research today that has him excited.
We have a lot to talk about! Are you ready for RealTalk MS??!
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/actrims03
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode
Guest: Dr. Peter CalabresiPrivacy Policy
-
It's MS Awareness Week, and the National MS Society is asking everyone in the MS community to tell MS exactly what they think of it. We're kicking off MS Awareness Week by introducing you to two difference-makers in the MS community who have each found their own way of talking back to MS.
Case Jernigan is an experimental animator, narrative gamemaker, and educator. His short animated documentary, Noggin, is currently making the rounds of the film festival circuit, raising awareness of how Case reacted and responded to his early symptoms of MS.
Suni Conway is an MS activist who has lived with MS for nearly 13 years. Suni uses her social media platform to raise awareness about MS diagnosis and treatment, and the need for healthcare reform.
Be sure to follow RealTalk MS all week long, as we celebrate MS Awareness Week with bonus episodes featuring conversations with leading MS experts from the 2025 ACTRIMS Forum!
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: It's MS Awareness Week! :22
Case Jernigan explains how his short animated documentary, Noggin, reflects the early parts of his MS journey 1:02
Suni Conway discusses the motivation behind her social media efforts and why advocacy is so important 12:05
Share this episode 35:52
Don't miss RealTalk MS bonus episodes all week long during MS Awareness Week! 36:12
Have you downloaded the free RealTalk MS app? 36:32
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/393
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSVIDEO: Noggin
https://vimeo.com/casejernigan/noggin
Suni Conway on Instagram
https://www.instagram.com/sunisideupprojectJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 393
Guests: Case Jernigan and Suni ConwayPrivacy Policy
-
Just a couple of weeks ago, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents gathered in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum.
Dr. Nara Michaelson is a Multiple Sclerosis Fellow at Harvard's Massachusetts General Hospital. We first talked with Dr. Michaelson last summer when her article, The Unraveling, was published in the journal, Neurology.
At the ACTRIMS Forum, we talked with Dr. Michaelson about how she uses arts therapy with her patients, and how lessons learned studying piano when she was 8 years old continue to serve her today in her work as an MS specialist.
We have a lot to talk about! Are you ready for RealTalk MS??!
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/actrims02
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode
Guest: Dr. Darin OkudaPrivacy Policy
-
Just a couple of weeks ago, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents gathered in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum.
Dr. Darin Okuda is the Director of the Multiple Sclerosis and Neuroimmunology Imaging Program, the Director of Neuroinnovation, and the Deputy Director of the Multiple Sclerosis Program and Clinical Center for Multiple Sclerosis at University of Texas Southwestern Medical Center.
At the ACTRIMS Forum, we talked with Dr. Okuda about the impact of artificial intelligence on MS care, how to go about preventing MS, and a frightening case study of what went wrong with an MS patient's generic disease-modifying therapy.
We have a lot to talk about! Are you ready for RealTalk MS??!
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/actrims01
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Bonus Episode
Guest: Dr. Darin OkudaPrivacy Policy
-
Last week, 1,800 scientists, clinicians, postdoctoral fellows, and medical residents arrived in West Palm Beach, Florida, for the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum.
I'm kicking off our coverage of this important conference by sharing two of the conversations I had at ACTRIMS 2025.
First, I talked with Dr. Lilyana Amezcua about the Alliance for Research in Hispanic Multiple Sclerosis, and her just-published paper, The Impact of Person-Centered Social Determinants and Neighborhood Deprivation Associated with Disability in Hispanic People with Multiple Sclerosis.
I also talked with Dr. John Corboy about aging and MS, and what he learned as the Principal Investigator of DISCO-MS, the largest clinical trial to focus on the question of whether it makes sense for someone over the age of 55 or 60 to discontinue their disease-modifying therapy.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: From the 2025 ACTRIMS Forum :22
Dr. Lilyana Amezcua discusses the Alliance For Research in Hispanic Multiple Sclerosis, and her paper focused on the impact of person-centered social determinants and neighborhood deprivation associated with disability in Hispanic people with multiple sclerosis 2:06
Dr. John Corboy discusses aging and MS, and what he learned as the Principal Investigator of DISCO-MS, the largest clinical trial to focus on the question of whether it makes sense for someone over the age of 55 or 60 to discontinue their disease-modifying therapy. 12:05
Share this episode 21:37
Next Week: Look for special episodes of the podcast with lots more interviews from the ACTRIMS Forum, featuring some of the leading MS experts in the world 21:57
Have you downloaded the free RealTalk MS app? 22:10
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/392
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSRESEARCH PARTICIPATION OPPORTUNITY: The Global PROMS Initiative eHealth Survey
https://proms-initiative.orgJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 392
Guests: Dr. Lilyana Amezcua and Dr. John CorboyPrivacy Policy
-
MS can limit your ability to get around and do the things you like to do. And when that happens, the right mobility device can be a game-changer when it comes to staying safe, staying active, and improving your quality of life.
This week, Dr. Evan Cohen joins me to discuss how to know when it's time to consider a mobility device, and how to choose the right mobility device for you.
We’re also presenting findings from two separate studies that shed significant light on how the gut microbiome interacts with the brain and how its composition varies among individuals with MS.
We'll tell you what happened when a research team gave a multiple-choice "test" measuring MS expertise to neurologists and neurology residents and then gave the same test to the leading artificial intelligence platforms.
And we'll share an opportunity for you to participate in MS research by taking the PROMS Initiative's eHealth survey.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Choosing the right mobility device :22
Differences in the gut microbiome of people with MS 1:28
Evidence shows the vagus nerve is the connection between the gut and the brain 3:53
Who won the "MS expertise" showdown between neurologists and AI? 6:18
Your opportunity to participate in MS research by taking the PROMS initiative survey 8:31
Dr. Evan Cohen shares everything you need to know about choosing a mobility device 10:27
Share this episode 30:57
Have you downloaded the free RealTalk MS app? 31:15
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/391
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSSTUDY: Alterations in Gut Microbiome-Host Relationships After Immune Perturbation in Patients with Multiple Sclerosis
https://neurology.org/doi/10.1212/NXI.0000000000200355
STUDY: Select Microbial Metabolites In the Small Intestinal Lumen Regulates Vagal Activity Via Receptor-Mediated Signaling
https://cell.com/iscience/fulltext/S2589-0042(24)02926-2STUDY: Artificial Intelligence Versus Neurologists: A Comparative Study on Multiple Sclerosis Expertise
https://sciencedirect.com/science/article/abs/pii/S030384672500068X
RESEARCH PARTICIPATION OPPORTUNITY: The Global PROMS Initiative eHealth Survey
https://proms-initiative.orgJoin the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 391
Guest: Dr. Evan CohenPrivacy Policy
-
This special episode of RealTalk MS is sponsored by Sanofi. By now, you may have come across the term smoldering MS and wondered what it means. An international panel of MS experts has published a consensus statement on the definition, biology, and clinical implications of smoldering MS. Joining me is the lead author of that paper, Dr. Antonio Scalfari.
Dr. Antonio Scalfari has a research background in multiple sclerosis and neuro-inflammatory conditions. From 2003 to 2006, he was a clinical fellow in the neurology department of Oxford University. In 2011, Dr. Scalfari obtained his PhD in neuro-epidemiology at Imperial College London, where he was then a post-doctorate research fellow from 2011 to 2013.
Since 2006, Dr. Scalfari has been working at the London North West Healthcare NHS Trust, and in 2013, he started working at the multiple sclerosis unit at Imperial College Healthcare NHS Trust. In 2017, Dr. Scalfari was appointed as a substantive consultant neurologist. Along with other consultants, he manages the multiple sclerosis and neuro-inflammatory diseases service at Charing Cross and St Mary's hospitals and is a general neurologist at London North West Healthcare NHS Trust.
Sanofi convened the meetings and paid for medical writing assistance, but the authors worked independently to develop and draft the consensus statement. While Dr. Scalfari has been compensated by Sanofi, his views and opinions are his own and do not necessarily reflect those of Sanofi.
-
More than half of the people living with MS live with pain. And, too often, the distraction and discomfort of MS-related pain can stop you from fully engaging in every aspect of your life.
Dr. Bianca Weinstock-Guttman joins me to discuss treatment options for managing MS pain. Dr. Weinstock-Guttman is a neurologist and professor of neurology at the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo, where she also serves as the Director of the Jacobs Multiple Sclerosis Center for Treatment and Research.
We're also taking a moment to respond to all your questions and concerns about the state of healthcare policy and administration in the U.S. federal government.
MS experts in Australia and New Zealand have released recommendations for MS care in those countries. We're sharing all the details.
We'll tell you about the National MS Society's initiative designed to improve access to MS care in rural communities in the U.S.
And we'll share the details of a study that shows that, together, obesity and smoking worsen MS symptoms faster.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Managing MS pain :22
Responding to your concerns about healthcare in the U.S. :57
Recommendations published for treating MS in Australia and New Zealand 7:16
National MS Society has launched an initiative designed to improve access to MS care in rural communities in the United States 9:09
Together, smoking and obesity worsen MS physical and cognitive symptoms faster 12:46
Dr. Bianca Weinstock-Guttman shares treatment options for managing MS pain 14:14
Share this episode 29:19
Have you downloaded the free RealTalk MS app? 29:38
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/390
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSConsensus Recommendations on Multiple Sclerosis Management in Australia and New Zealand
https://mja.com.au/journal/2025/222/7/consensus-recommendations-multiple-sclerosis-management-australia-and-new
STUDY: Smoking and Obesity Interact to Adversely Affect Disease Progression and Cognitive Performance in Multiple Sclerosis
https://onlinelibrary.wiley.com/doi/10.1111/ene.70058Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 390
Guest: Dr. Bianca Weinstock-GuttmanPrivacy Policy
-
Living your best life with MS means learning to overcome the stigma of having a disability, successfully navigating social relationships, and learning how to ask for and accept help.
Joining me to share their perspectives and their experiences in overcoming some of these social obstacles are Denise Schnieders, who was diagnosed with MS just about a year ago, and Fox Rigney, who's been living with MS since 2012.
We're also applauding a forward-thinking caregiver leave benefit that's just been announced by EMD Serono.
We're sharing results of a study that show MS lesions dynamically change over time and explains why those changes aren't apparent on MRI scans.
We'll tell you about an AI-powered drug repurposing platform that has identified a potential treatment for MS.
We'll also share an announcement from the CEO of Google's artificial intelligence company, DeepMind, that we will see pharmaceutical drugs developed by artificial intelligence in clinical trials by the end of this year.
And we'll share the details of a Phase 2 clinical trial that you may qualify to participate in.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Overcoming the stigma of disability, navigating social situations, and how to ask for and receive help :22
EMD Serono implements caregiver leave benefit (And we're applauding!) 1:04
Imaging study reveals that T-2 lesions expand and contract "invisibly" 3:16
Has an AI drug repurposing platform discovered a new treatment for MS? 6:22
We will see pharmaceutical drugs developed by artificial intelligence in clinical trials this year 8:06
Your opportunity to participate in MS resesarch 10:54
Denise Schnieders and Fox Rigney discuss overcoming the stigma of MS 14:04
Share this episode 32:46
Have you downloaded the free RealTalk MS app? 33:06
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/389
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSDynamic Expansion and Contraction of Multiple Sclerosis T-2 Weighted Hyperintense Lesions Are Present Below the Threshold of Visual Perception
https://www.ajnr.org/content/early/2025/01/16/ajnr.A8453
Contact Information for Obexelimab Phase 2 Clinical Trial
Phone: (833) 269-4696
Email: [email protected]Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 389
Guests: Denise Schnieders and Fox RigneyPrivacy Policy
-
When we talk about myelin damage, most of us typically think of the brain. After all, that myelin is located in your central nervous system. But the inflammation that causes myelin damage may be triggered by activity that's taking place well south of your central nervous system, in your gut microbiome, the colony of trillions of bacteria and microorganisms that live in your intestines.
Dr. Ashutosh Mangalam joins me to help us understand what this gut-brain connection is all about, how that connection impacts MS, and what you can do to change the makeup of your gut microbiome. Dr. Mangalam is an Associate Professor of Pathology at the Carver College of Medicine at the University of Iowa, where his research is focused on studying the gut microbiome and the immune system in multiple sclerosis.
We're also talking about the newly published guidance from the European Committee for Treatment and Research in MS and the European Society for Blood and Marrow Transplantation, recommending autologous hematopoietic stem cell transplantation (aHSCT) for treating some cases of relapsing-remitting MS.
We'll tell you about an experimental drug that may resolve MS-related vision issues through remyelination.
And we'll introduce you to this year's winner of the Barancik Prize for Innovation in MS Research.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: The gut-brain connection (and what it means if you're liviing with MS) :22
The European Committee for Treatment and Research in MS and the European Society for Blood and Marrow Transplantation issue a recommendation for stem cell therapy to treat relapsing-remitting MS 1:35
Researchers develop a drug that may resolve MS-related vision issues through remyelination 4:44
National MS Society names this year's winner of the Barancik Prize for Innovation in MS Research 7:23
Dr. Ashutosh Mangalam explains how (and why) the brain-gut connection impacts MS 11:14
Share this episode 35:38
Have you downloaded the free RealTalk MS app? 35:58
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/388
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSAutologous Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder -- Recommendations from ECTRIMS and EBMT
https://www.nature.com/articles/s41582-024-01050-x
National MS Society Releases Recommendations for aHSCT-Bone Marrow Transplant for MS
https://nationalmssociety.org/news-and-magazine/news/national-ms-society-releases-recommendationsSTUDY: Incomplete Remyelination Via Therapeutically Enhanced Oligodendrogenesis Is Sufficient to Recover Visual Cortical Function
https://www.nature.com/articles/s41467-025-56092-6Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 388
Guest: Dr. Ashutosh MangalamPrivacy Policy
-
The TEAAMS study examines the effects of a remotely delivered, racially-tailored exercise training program among African-Americans with MS, who are living in low-income areas of the Southeastern United States, which is a part of the country that doesn't have many primary care or MS clinics that provide full exercise and rehabilitation services for patients with MS.
Ashli, who lives with MS and has completed the TEAAMS program, and Victoria, a behavioral coach who has worked with several study participants, join me this week to share their experiences in the study.
We're also talking about a new Phase1/2 clinical trial for another investigative CAR-T therapy. (And we'll explain what a Phase 1/2 trial is)
We'll tell you about TG Therapeutics' plans for Briumvi, as well as their investigative CAR-T therapy.
We'll tell you about the Phase 2 clinical trial for Contineum Therapeutics' oral remyelination therapy.
We'll share the details of a study that shows ballroom dancing delivers both physical and psychological benefits to people with MS.
We'll share some potentially good news about managing MS-related fatigue.
And we'll give you a new opportunity to participate in MS research.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Inside the TEAAMS study :22
Cabaletta Bio announces Phase 1/2 trial for CAR-T therapy 1:45
TG Therapeutics will develop an injectable formulation for Briumvi 5:45
Contineum Therapeutics completes recruitment for Phase 2 trial for an oral remyelination therapy 7:52
Study shows that ballroom dancing delivers physical and psychological benefits for people with MS 9:05
Study shows that Elevida, an online German fatigue intervention, significantly reduces MS-related fatigue 11:32
Ashli and Victoria share their experience in the TEAAMS study 15:37
Share this episode 32:57
Have you downloaded the free RealTalk MS app? 33:17
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/387
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSSTUDY: Ballroom Dancing for People with Multiple Sclerosis: Perceptions of the Experience
https://meridian.allenpress.com/ijmsc/article/26/Q4/355/504470/Ballroom-Dancing-for-People-With-Multiple
PARTICIPATE IN MS RESEARCH: Targeted Exercise for African-Americans with Multiple Sclerosis (TEAAMS)
https://projectteaams.ahs.uic.edu/PARTICIPATE IN MS RESEARCH: Confirmatory Trial for Alleviating Fatigue in MS (CAFE-MS)
https://cafems.iconquerms.org/Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 387
Guests: Ashli and VictoriaPrivacy Policy
-
MS symptoms can worsen, and relapses can occur. And when that happens, how do you know whether you require immediate medical care? When is it time to go to the hospital? Dr. Kalina Sanders joins me to talk about when it's time to seek immediate medical care for MS.
Dr. Sanders is a board-certified neurologist who specializes in multiple sclerosis and spasticity management at Baptist Health in Jacksonville Beach, Florida.
We're also talking about MS care in the United Arab Emirates with Professor Bassem Yamout, the President of the Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis.
We'll explain why Bayer's new MRI contrast agent is good news for people with MS.
We'll tell you about a new Federal Trade Commission report that calls out Pharmacy Benefit Managers for inflating the price of generic specialty drugs by thousands of percent.
We'll share the details of a study that shows the profound impact of menopause on MS.
And we're sharing two different opportunities for you to participate in MS research.
We have a lot to talk about! Are you ready for RealTalk MS??!
A word about Facebook posts :22
This Week: Worsening symptoms? Relapse? When is it time to go to the Emergency Room? 1:46
FTC reports Pharmacy Benefit Managers have marked up generic specialty drugs 1000s of percent 2:20
Bayer's new MRI contrast agent contains 60% less gadolinium 4:57
Professor Bassem Yamout discusses MS in the United Arab Emirates 6:48
Study reveals menopause significantly increases the speed of disability worsening and brain cell damage in women with MS 15:08
Two opportunities for you to participate in MS research 17:38
Dr. Kalina Sanders explains when it's time to seek immediate medical care for MS 19:54
Share this episode 31:42
Have you downloaded the free RealTalk MS app? 32:02
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/386
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSFederal Trade Commission Interim Report on Pharmacy Benefit Managers and Specialty Generic Drugs
https://www.ftc.gov/reports/specialty-generic-drugs-growing-profit-center-vertically-integrated-pharmacy-benefit-managers
Bayer Announces MRI Contrast Agent Gadoquatrane Meets Primary and Main Secondary Endpoints in Pivotal Phase III Studies
https://www.businesswire.com/news/home/20250109869429/en/Bayers-investigational-MRI-contrast-agent-gadoquatrane-meets-primary-and-main-secondary-endpoints-in-pivotal-Phase-III-studiesSTUDY: Association of Menopause with Functional Outcomes and Disease Biomarkers in Women with Multiple Sclerosis
https://www.neurology.org/doi/10.1212/WNL.0000000000210228
PARTICIPATE IN MS RESEARCH: Psychometric Properties of Sexual Difficulties Scales in People Living with Multiple Sclerosis
https://qualtrics.kcl.ac.uk/jfe/form/SV_br1fVoYGqXnLooKPARTICIPATE IN MS RESEARCH: Efficacy and Safety Study of Frexalimab in Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
https://www.sanofistudies.com/SR0A/Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 386
Guests: Professor Bassem Yamout, Dr. Kalina SandersPrivacy Policy
-
This special episode of RealTalk MS is sponsored by EMD Serono and is only intended for a U.S. audience. EMD Serono is the healthcare business of Merck, KGaA, Darmstadt, Germany, in the United States and Canada.
In this special episode of RealTalk MS, Dr. Mary Rensel and Amanda Montague join me to explore HCP (Healthcare Provider) burnout and patient empowerment; and we'll be taking a close look at how patients and their healthcare providers can work together to support one another.
Dr. Mary Rensel is an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine and Director of Pediatric Multiple Sclerosis and Wellness at the Mellen Center for Multiple Sclerosis at the Cleveland Clinic.
Amanda Montague is a global thought leader and Chief Mission Officer at the Multiple Sclerosis Association of America. Amanda is also an active member of the MS in the 21st Century initiative, more commonly known as MS21. MS21 is a Merck KGaA, Darmstadt, Germany, initiative involving healthcare professionals, or HCPs, and patient advocates.
To learn more about MS in the 21st Century, please visit www.msinthe21stcentury.com.
-
The new year brings with it several significant benefits for many people affected by MS. We're reviewing how the nearly 400,000 people with MS who rely on Medicare for their health insurance will save thousands of dollars, how people with MS who currently have medical debt will see a big improvement on their credit report, and how people who fly with their mobility device will see major improvements in how the airlines treat them.
We're also talking with Craig Bianco about his experience as a member of the Care Partner Advisory Board creating the MS Care Partner Connection web portal.
And we'll tell you about the Phase 1 clinical trial for the Epstein-Barr Virus vaccine that's getting underway.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Where to get support if you have MS and you're a victim of the Southern California fires :22
Here's where and how 2025 is delivering new and improved benefits for many people with MS 2:06
Department of Transportation adopts new rules to improve flying for people with disabilities 10:26
Modex Therapeutics, in collaboration with Merck, announces Phase 1 clinical trial for Epstein-Barr Virus vaccine 14:03
Craig Bianco talks about his experience as a member of the Care Partner Advisory Board creating the MS Care Partner Connection web portal 17:26
Share this episode 29:12
Have you downloaded the free RealTalk MS app? 29:32
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/385
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSMS Care Partner Connection
https://mscarepartnerconnection.com
Find Out How You Can Become an MS Activist
https://nationalmssociety.org/advocacyRealTalk MS Episode 302: De-Stressing Air Travel if You're Living with MS with Dr. Scott Crawford
https://realtalkms.com/302Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 385
Guest: Craig BiancoPrivacy Policy
-
There are genetic risks associated with MS, there are demographic risks of experiencing a more severe disease course, and there are also behavioral and lifestyle risks that will increase the chance that someone will be diagnosed with MS. Joining me today to discuss behavioral and lifestyle MS risk factors and how they can be mitigated are Doctor Jared Bruce and Dr. Amanda Bruce.
Dr. Jared Bruce is a neuropsychologist and the director of psychiatric research at the University of Missouri-Kansas City School of Medicine. Dr. Amanda Bruce is a clinical psychologist and an assistant professor in the Department of Behavioral Pediatrics at the University of Kansas Medical Center.
We're also reviewing the details of the Inflation Reduction Act, which means, beginning in 2025, significantly lower out-of-pocket costs for prescription medications for the quarter-million people with MS who are on Medicare.
We'll tell you about study results for a novel drug that was effective in remyelination and restoring lost function to mice with the mouse model of MS.
We'll share the details of a study that shows how specific comorbidities affect specific MS outcomes.
We'll review results of a study that shows men with MS who start a high-efficacy disease-modifying therapy experience fewer relapses.
And we'll tell you how an artificial intelligence chatbot soundly beat human experts in predicting the results of neuroscience studies.
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Behavioral and Lifestyle risk factors for MS (and how to mitigate them) :22
It's 2025, and that means significant out-of-pocket savings on prescription medications for people with MS on Medicare 1:20
Novel drug shows effectiveness in remyelination and restoring function in mouse model of MS 3:26
Study shows how specific comorbidities affect specific MS outcomes 5:17
Study shows men on high-efficacy disease-modifying therapies experience fewer MS relapses 8:46
Study shows AI beats human experts in predicting results of neuroscience studies 12:22
Dr. Jared Bruce and Dr. Amanda Bruce discuss behavioral and lifestyle MS risk factors 16:43
Share this episode 32:13
Have you downloaded the free RealTalk MS app? 32:33
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/384
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS on YouTube
https://www.youtube.com/@RealTalkMSSTUDY: Selective Retinoid X Receptor Agonism Promotes Functional Recovery and Myelin Repair in Experimental Autoimmune Encephalomyelitis
https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-024-01904-x
STUDY: Comorbidities and Their Association with Outcomes In the Multiple Sclerosis Population: A Rapid Review
https://msard-journal.com/article/S2211-0348(24)00519-4/fulltextSTUDY EXPLAINED (Plain English): Comorbidities and Their Association with Outcomes In the Multiple Sclerosis Population: A Rapid Review
https://tremlettsmsresearchexplained.wordpress.com/2024/10/29/comorbidities-and-their-association-with-outcomes-in-the-multiple-sclerosis-population-a-rapid-review-explained
STUDY: Comparative Effectiveness of High-Efficacy and Moderate-Efficacy Disease-Modifying Agents in Reducing the Annualized Relapse Rates Among Multiple Sclerosis Patients in the United States
https://sciencedirect.com/science/article/abs/pii/S0091743524003359STUDY: Large Language Models Surpass Human Experts in Predicting Neuroscience Results
https://nature.com/articles/s41562-024-02046-9Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 384
Guests: Dr. Jared Bruce and Dr. Amanda BrucePrivacy Policy
-
One of the most important MS research events every year is the annual European Committee for Treatment and Research in MS Scientific Congress, usually referred to by its acronym, ECTRIMS. You've made our podcast episode that followed ECTRIMS the most downloaded episode of the year. So, this week, I'm revisiting the two conversations that I had immediately after the ECTRIMS conference ended. In what has become an annual tradition, it's my privilege to sit down with the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, just minutes after the conclusion of ECTRIMS to get his first impressions of the news and presentations that caught his eye. This year, I also wanted to bring you the perspective of someone who's living with MS, who attended ECTRIMS for the very first time. So, less than an hour after the conference concluded, I had a conversation with Kristine Werner Ozug. (Full disclosure, Kristine is a member of the RealTalk MS team.)
We have a lot to talk about! Are you ready for RealTalk MS??!
This Week: Revisiting ECTRIMS 2024 :22
Dr. Bruce Bebo shares the announcements and presentations that caught his eye at ECTRIMS 1:59
Kristine Werner Ozug shares a patient's perspective on attending the largest MS research conference in the world 14:07
Share this episode 26:54
Have you downloaded the free RealTalk MS app? 27:14
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/383
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS at ECTRIMS on YouTube
https://www.youtube.com/playlist?list=PLATxgj1uHpxPOTklQKDkASWTEBoHXVGH1Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 383
Guests: Dr. Bruce Bebo and Kristine Werner OzugPrivacy Policy
-
The holiday season provides me with an opportunity to indulge in what's become a RealTalk MS tradition. I reserve the last two episodes of the year to revisit the most compelling and important conversations that I've had over the past year. This week, I'm revisiting two conversations I had with two experts on MS and women's health issues. MS affects women almost 3 times more frequently than it affects men, which should make understanding how MS might impact other women's health issues a priority. Unfortunately, that hasn't really been the case. The good news is we're seeing that situation change and you can expect to hear much more about MS and women's health in the coming year. This brings me to two conversations that I had this past year when I talked with Dr. Rhonda Voskuhl and Dr. Anna Shah. Dr. Shah is an Associate Professor of Neurology and Associate Clinic Director of Outpatient Neurology at the University of Colorado School of Medicine. Dr. Voskuhl is the Director of the UCLA Multiple Sclerosis Program, she holds the Jack H. Skirball Chair in MS, and Dr. Voskuhl also serves as Faculty Neurologist of the UCLA Comprehensive Menopause Care Program.
We have a lot to talk about! Are you ready for RealTalk MS??!
Happy Holidays! :22
This Week: Revisiting our deep dive into women's health and MS :44
Dr. Rhonda Voskuhl discusses her research looking at why MS affects men and women differently 2:34
Dr. Anna Shah discusses how MS can affect women's health issues and how those health issues can affect MS 13:30
Share this episode 32:18
Have you downloaded the free RealTalk MS app? 32:38
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/382
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Email: [email protected]
Phone: (310) 526-2283And don't forget to join us in the RealTalk MS Facebook group!
LINKS
If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com
RealTalk MS at ECTRIMS on YouTube
https://www.youtube.com/playlist?list=PLATxgj1uHpxPOTklQKDkASWTEBoHXVGH1Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkmsDownload the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalkGive RealTalk MS a rating and review
http://www.realtalkms.com/reviewFollow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 382
Guests: Dr. Anna Shah, Dr. Rhonda VoskuhlPrivacy Policy
- Laat meer zien
